Go-ahead for ‘pharmed’ goat drug

Author (Corporate)
Series Title
Series Details 2.6.06
Publication Date 02/06/2006
Content Type

The first medicine produced from a genetically modified animal has been recommended for use in Europe by the European Medicines Agency (EMEA), June 2006. EMEA has adopted the first positive opinion for a medicinal product derived from transgenic biotechnology. ATryn, from Genzyme Europe, contains antithrombin alfa, a recombinant-DNA human anti-clotting blood protein. Antithrombin alfa is extracted from the milk of goats which have the human antithrombin gene inserted, that enables them to produce the human protein in their milk.

Source Link Link to Main Source http://news.bbc.co.uk/1/hi/sci/tech/5041298.stm
Related Links
EMEA: Press Release, 2.6.06: European Medicines Agency adopts first positive opinion for a medicinal product derived from transgenic http://www.emea.eu.int/pdfs/general/direct/pr/20316306en.pdf

Subject Categories
Countries / Regions